Buy Olumiant (baricitinib)
Olumiant (baricitinib) is a medication used for the treatment of rheumatoid arthritis and for the treatment of moderate to severe atopic dermatitis.
On November 19, 2020 the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for Olumiant (baricitinib), in combination with Veklury (remdesivir), to treat COVID-19 patients.
